Bioxytran, Inc.
BIXT
$0.109
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.26% | 52.44% | 37.54% | -9.51% | -81.79% |
| Total Depreciation and Amortization | -20.41% | -4.82% | 62.96% | 102.22% | 206.25% |
| Total Amortization of Deferred Charges | 94.43% | 94.43% | -84.55% | -94.32% | 57.67% |
| Total Other Non-Cash Items | 28.23% | 187.54% | 4.58% | 2,607.76% | 1,173.22% |
| Change in Net Operating Assets | -49.41% | -70.25% | -25.84% | 55.57% | 238.30% |
| Cash from Operations | 78.87% | 88.42% | 73.02% | 50.70% | 46.35% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.10% | 36.12% | 42.71% | 24.14% | -212.33% |
| Cash from Investing | 51.10% | 36.12% | 42.71% | 24.14% | -212.33% |
| Total Debt Issued | 5.53% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -89.28% | -89.28% | -91.23% | -37.81% | -19.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -200.00% |
| Cash from Financing | -72.66% | -82.38% | -65.24% | -25.30% | -17.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.11% | 92.24% | 84.48% | 93.04% | 75.45% |